The Valley Desk

NCT02807272 · Interventional trial

Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia

Overall registry status Completed

Phase 2

Conditions Leukemia, Myelomonocytic, Chronic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov